TRANSFUSION SUPPORT--CORE
输血支持--核心
基本信息
- 批准号:3816014
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The success of marrow transplantation is heavily dependent on the
transfusion of blood products and is a situation which provides
many opportunities for research in transfusion immunology. In
Project IX we have described our research proposals for problems
of platelet alloimmunization. In Project III we describe our
proposals for the utilization of blood products screened for
antibody to cytomegalovirus (CMV) as well as an evaluation of
leukocyte-depleted blood products for the prevention of CMV. In
this core section we are concerned with mechanisms for deriving
research information from clinically necessary transfusion support
and plasma modification procedures. We ask support only for key
personnel for supervision and data entry where we cannot recover
costs from charges but where the work is essential to carrying out
the proposed research in individual program projects. These areas
include establishing and maintaining data bases containing
detailed descriptive information on all blood product transfusions
and on the course and outcome of all ABO-incompatible
transplants requiring plasma modification or marrow red cell
depletion.
骨髓移植的成功在很大程度上取决于
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM I BENSINGER其他文献
WILLIAM I BENSINGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM I BENSINGER', 18)}}的其他基金
Targeted Radiotherapy with 90Y-BC8 Monclonal Antibody, Fludarabine and TBI Follow
90Y-BC8 单克隆抗体、氟达拉滨和 TBI 靶向放射治疗
- 批准号:
8038924 - 财政年份:2011
- 资助金额:
-- - 项目类别: